Cardiol Therapeutics Inc. (CRDL) Financials

CRDL Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 20.7 million 3.8 million
March 31, 2026 22.6 million 5.2 million
Dec. 31, 2025 17.2 million 4.2 million
Sept. 30, 2025 9.3 million 2.4 million

CRDL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.1 million ?
March 31, 2026 -5.4 million 1.3 million
Dec. 31, 2025 -3.8 million 2.2 million
Sept. 30, 2025 -5.0 million 2.9 million

CRDL Net Income

No data available :(

CRDL Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 18.4 million - -
March 31, 2026 19.9 million - 83478
Dec. 31, 2025 15.6 million - 91556
Sept. 30, 2025 8.3 million - 96378

CRDL Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 80.9 million
March 31, 2026 78.2 million
Dec. 31, 2025 73.1 million
Sept. 30, 2025 60.8 million

CRDL Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 2133 3.2 million 4.7 million -
March 31, 2026 34214 3.6 million 3.4 million -
Dec. 31, 2025 2252 2.0 million 3.8 million -
Sept. 30, 2025 2167 3.4 million 3.9 million -

CRDL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - 19202
Dec. 31, 2025 - 18930
Sept. 30, 2025 - -

CRDL

Price: $1.32

52 week price:
0.88
2.29

Earnings Per Share: -0.25 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: Canada

Volume: 88200

Market Capitalization: 248.4 million

Links: